This website is not an offer to sell any securities. Offers can be only be made to accredited investors in jurisdictions where the offer or sale can legally be made.
Authorized Shares: 75,000,000
Outstanding shares: 19,546,856
Float: 2,370,279
Total number of shareholders: 200
Nevada since October 23, 2003
Par or stated value: $0.001
Transfer Agent
Name: Action Stock Transfer
Phone: 801-274-1088
Email: jb@actionstocktransfer.com
In 1970, President Richard Nixon’s Comprehensive Drug Abuse Prevention and Control Act added marijuana to the list of Schedule I drugs under the Controlled Substances Act. Despite the fact that hemp contained only trace amounts of THC, hemp was included in the federal ban and was lumped in with highly psychoactive and/or addictive Schedule I drugs such as heroin and LSD. While marijuana remains a Schedule I drug today, hemp was removed from the Controlled Substance Act ban list in December 2018 thanks to the Farm Bill, opening the doors for legal CBD production in the U.S.
Since CBD derived from hemp has been legal in the U.S. for less than a year, the regulatory restrictions on the compound are still up in the air. CBD falls under the jurisdiction of the FDA, which is expected to provide some clarity on potential restrictions by the end of 2019.
Since the 2018 Farm Bill, 46 U.S. states have enacted hemp production laws. The number of total hemp acres planted nationwide tripled in 2018 to 78,176, with Montana (22,000 acres) and Colorado (21,578) leading the way. Carey estimates the 2018 U.S. hemp crop could have theoretically produced about 2.5 million kilograms of CBD. If no more than 3% of the U.S. population were consuming CBD and 100% of the hemp crop were converted to CBD, Carey says the U.S. already has the CBD production capacity to meet market demand.
A message from Compliance:
This website is not an offer to sell any securities.
Offers can be only be made to accredited investors in jurisdictions where the offer or sale can legally be made.
1. This website contains “forward-looking statements” as that term is defined in the Private Securities Litigation
Reform Act of 1995. For this purpose, any statements contained herein or which are otherwise made by or on behalf
of the Company that are not statements of historical facts may be deemed forward-looking statements. Without
limiting the generality of the foregoing, words such as “may,” “will,” “to,” “plan,” “expect,” “believe,”
“anticipate,” “intend,” “could,” “should,” “would,” “estimate,” or “continue,” or the negative orother variations
thereof or comparable terminology are intended to identify forward-looking statements. Shareholders are cautioned
that all forward-looking statements involve risk and uncertainties which may cause results to differ materially
from those set forth in the statements. Such risks and uncertainties include, but are not limited to the following:
the success of research and development activities and the speed with which regulatory authorizations and product
launches may be achieved; government regulation generally; competitive developments; the ability to successfully
market products domestically and internationally; difficulties or delays in manufacturing or issues relating to
manufacturing capacity; commercial obstacles to the successful introduction of brand products generally; legal
defense costs, insurance expenses, settlement costs, and the risk of an adverse decision or settlement relating
to product liability, patent protection, governmental investigations, and other legal proceedings; the Company’s
ability to acquire and protect patents and other intellectual property both domestically and internationally; the
absence of certainty regarding the receipt of required regulatory approval or the timing, costs, or terms of such
approvals; any changes in business, political and economic conditions; business interruption due to hurricanes or
other events outside of the Company’s control; and the Company's access to and receipt of sufficient capital to
be able to pursue its business and business objectives.Readers are cautioned not to place reliance on these
forward-looking statements, which are valid only as of the date they were made. The Company undertakes no
obligation to update or revise any forward-looking statements to reflect new information or the occurrence of
unanticipated events or otherwise, except as expressly required by law.
4350 Oakes Rd
Suite 510
Davie, FL 33314
info@nxgenbrands.com
+1-888-315-6339